BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3040% above fair value
$72.80−0.02 (-0.03%)
Close on Nov 11, 2026Market cap $11.43BP/E 66.8Yield 0.44%
Bio-Techne enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bio-Techne's enterprise value was $11.30B on Nov 11, 2026, against $10.20B a year earlier. Over the last 5 years it ranged from $7.78B to $20.39B, with a median of $11.53B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $11.30B | +21.3% |
| 2025 | Dec 31, 2025 | $9.31B | -19.4% |
| 2024 | Dec 31, 2024 | $11.56B | -7.6% |
| 2023 | Dec 29, 2023 | $12.51B | -4.3% |
| 2022 | Dec 30, 2022 | $13.07B | -35.9% |
| 2021 | Dec 31, 2021 | $20.39B | +64.3% |
| 2020 | Dec 31, 2020 | $12.41B | +41.9% |
| 2019 | Dec 31, 2019 | $8.75B | +47.3% |
| 2018 | Dec 31, 2018 | $5.94B | +16.2% |
| 2017 | Dec 29, 2017 | $5.11B | +24.4% |
| 2016 | Dec 30, 2016 | $4.11B | +18.7% |
| 2015 | Dec 31, 2015 | $3.46B | +0.8% |
| 2014 | Dec 31, 2014 | $3.44B | +0.9% |
| 2013 | Dec 31, 2013 | $3.40B | +42.7% |
| 2012 | Dec 31, 2012 | $2.39B | -0.3% |
| 2011 | Dec 30, 2011 | $2.39B | +5.8% |
| 2010 | Dec 31, 2010 | $2.26B | -7.3% |
| 2009 | Dec 31, 2009 | $2.44B | – |
See a number that looks wrong?